X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (476) 476
Publication (50) 50
Book Chapter (10) 10
Book Review (5) 5
Book / eBook (3) 3
Patent (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (295) 295
female (293) 293
index medicus (244) 244
oncology (218) 218
cancer (147) 147
obstetrics & gynecology (136) 136
middle aged (118) 118
adult (110) 110
aged (91) 91
pregnancy (90) 90
chemotherapy (87) 87
endometrial cancer (71) 71
prognosis (66) 66
endometrial neoplasms - pathology (63) 63
carcinoma (62) 62
neoplasm staging (55) 55
hematology, oncology and palliative medicine (51) 51
aged, 80 and over (47) 47
tumors (46) 46
obstetrics and gynecology (43) 43
surgery (43) 43
ovarian cancer (42) 42
research (41) 41
breast-cancer (39) 39
care and treatment (37) 37
endometrial neoplasms - genetics (35) 35
animals (34) 34
risk factors (33) 33
survival (33) 33
treatment outcome (32) 32
retrospective studies (31) 31
women (31) 31
ovarian neoplasms - pathology (30) 30
expression (29) 29
management (29) 29
pregnant women (28) 28
ovarian neoplasms - drug therapy (26) 26
immunohistochemistry (25) 25
analysis (24) 24
case-control studies (24) 24
health aspects (24) 24
radiotherapy (24) 24
risk (24) 24
breast cancer (23) 23
uterus (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
medicine & public health (22) 22
metastasis (22) 22
oncology, experimental (22) 22
uterine neoplasms - pathology (22) 22
antineoplastic agents - adverse effects (21) 21
mice (21) 21
ovarian neoplasms - surgery (21) 21
paclitaxel (21) 21
pathology (21) 21
therapy (21) 21
young adult (21) 21
diagnosis (20) 20
endometrial neoplasms - surgery (20) 20
genetic predisposition to disease (20) 20
hospitals (20) 20
male (20) 20
antineoplastic agents - therapeutic use (19) 19
genetic aspects (19) 19
neoplasm recurrence, local - pathology (19) 19
pregnancy complications, neoplastic - diagnosis (19) 19
prospective studies (19) 19
disease-free survival (18) 18
pregnancy complications, neoplastic - therapy (18) 18
endometrial neoplasms - drug therapy (17) 17
endometrial neoplasms - mortality (17) 17
endometrium (17) 17
medical research (17) 17
mutation (17) 17
paclitaxel - administration & dosage (17) 17
sarcoma (17) 17
survival analysis (17) 17
transplacental transfer (17) 17
biopsy (16) 16
carboplatin - administration & dosage (16) 16
endometrial neoplasms - diagnosis (16) 16
gynecologic-oncology-group (16) 16
lymphatic metastasis (16) 16
quality of life (16) 16
biomarkers, tumor - genetics (15) 15
chemotherapy, adjuvant (15) 15
gene expression (15) 15
hysterectomy (15) 15
kaplan-meier estimate (15) 15
neoadjuvant chemotherapy (15) 15
ovarian neoplasms - genetics (15) 15
patients (15) 15
polymorphism, single nucleotide (15) 15
pregnancy complications, neoplastic - drug therapy (15) 15
studies (15) 15
biomarkers (14) 14
breast neoplasms - drug therapy (14) 14
endometrial neoplasms - therapy (14) 14
immunotherapy (14) 14
neoplasms (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Pathology, ISSN 0893-3952, 05/2018, Volume 31, Issue 5, pp. 816 - 828
Journal Article
Nature reviews cancer, ISSN 1474-175X, 04/2017, Volume 17, Issue 4, pp. 254 - 268
Journal Article
Journal Article
Lancet Oncology, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 256 - 264
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2012, Volume 109, Issue 3, pp. 929 - 934
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2016, Volume 156, Issue 2, pp. 319 - 330
Journal Article
Sarcoma, ISSN 1357-714X, 2015, Volume 2015, pp. 243298 - 14
Uterine sarcomas are rare tumors accounting for 3,4% of all uterine cancers. Even after radical hysterectomy, most patients relapse or present with distant... 
Uterine diseases | Molecular targeted therapy | Care and treatment | Genetic aspects | Sarcoma | Innovations | Review
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 04/2012, Volume 10, Issue 4, pp. 258 - 259
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2018, Volume 142, Issue 6, pp. 1230 - 1243
Uterine leiomyosarcomas (uLMS) are rare, aggressive malignancies for which limited treatment options are available. To gain novel molecular insights into uLMS... 
RNA sequencing | uterine leiomyosarcoma | copy number alteration | data integration | molecular profiling | MOLECULAR SUBTYPES | TUMOR PROGRESSION | VARIANTS | DOXORUBICIN | CANCER GENOMES | IMPACT | INHIBITION | ONCOLOGY | EXPRESSION | CARCINOMA | SOFT-TISSUE SARCOMA | Uterine Neoplasms - therapy | Uterine Neoplasms - pathology | Humans | Middle Aged | Receptors, Vasoactive Intestinal Peptide, Type II - genetics | Aged, 80 and over | Leiomyosarcoma - genetics | Uterine Neoplasms - mortality | Adult | Female | Genomics - methods | High-Throughput Nucleotide Sequencing - methods | Genes, Tumor Suppressor | Gene Expression Regulation, Neoplastic - genetics | Uterine Neoplasms - genetics | Oncogenes - genetics | Cell Proliferation - genetics | Leiomyosarcoma - pathology | Myometrium - pathology | Carcinogenesis - genetics | Kaplan-Meier Estimate | Signal Transduction - genetics | Whole Genome Sequencing - methods | Leiomyosarcoma - therapy | Sequence Analysis, RNA - methods | Leiomyosarcoma - mortality | Aged | RNA | Analysis | Genes | Genomics | Estrogen | Leiomyosarcoma | Genetic research | Genomes | Tumor proteins | Gene expression | TOR protein | Cell proliferation | Drugs | Target recognition | Copy number | p53 Protein | Estrogens | DNA damage | Smooth muscle | AKT protein | Gene deletion | Multivariate analysis | Drug development | Alterations | Cell growth | Pathways | Clonal deletion | Uterus | Data integration | Deletion | Deoxyribonucleic acid--DNA | Myometrium | Muscles | Data processing | Patients | 1-Phosphatidylinositol 3-kinase | Signaling | Vasoactive intestinal peptide | Tumor suppressor genes | Mutation | Uterine cancer | PTEN protein | Cancer | Fibroblast growth factor receptors
Journal Article